CNPAX
Price
$60.04
Change
+$1.14 (+1.94%)
Updated
Apr 24 closing price
Net Assets
134.95B
FNPFX
Price
$61.16
Change
+$1.16 (+1.93%)
Updated
Apr 24 closing price
Net Assets
134.95B
Ad is loading...

CNPAX vs FNPFX

Header iconCNPAX vs FNPFX Comparison
Open Charts CNPAX vs FNPFXBanner chart's image
American Funds New Perspective 529A
Price$60.04
Change+$1.14 (+1.94%)
VolumeN/A
Net Assets134.95B
American Funds New Perspective F3
Price$61.16
Change+$1.16 (+1.93%)
VolumeN/A
Net Assets134.95B
CNPAX vs FNPFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNPAX vs. FNPFX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and FNPFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CNPAX (135B) and FNPFX (135B) have equal amount of cash in the bank . FNPFX pays higher dividends than CNPAX: FNPFX (0.90) vs CNPAX (0.55). CNPAX was incepted earlier than FNPFX: CNPAX (23 years) vs FNPFX (8 years). CNPAX (0.77) is less costly to investors than FNPFX (0.41). CNPAX (24.00) and FNPFX (24.00) have comparable annual turnover. CNPAX has a lower initial minimum investment than FNPFX: CNPAX (250) vs FNPFX (1000000). FNPFX annual gain was more profitable for investors over the last year : 4.64 vs. CNPAX (4.18). FNPFX (49.33) and CNPAX (48.42) have equivalent 5 years return.
CNPAXFNPFXCNPAX / FNPFX
Total Expense Ratio0.770.41188%
Annual Report Gross Expense Ratio0.770.41188%
Fund Existence23 years8 years-
Gain YTD-1.622-1.514107%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets135B135B100%
Annual Yield % from dividends0.550.9062%
Returns for 1 year4.184.6490%
Returns for 3 years12.1712.3499%
Returns for 5 years48.4249.3398%
Returns for 10 years63.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBA2.280.12
+5.56%
Akebia Therapeutics
GLTO2.850.10
+3.64%
Galecto Inc
CATO2.480.08
+3.33%
CATO Corp
AFRM48.201.36
+2.90%
Affirm Holdings
ACAD14.830.21
+1.44%
ACADIA Pharmaceuticals